“Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis and Skin of Color”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s549. https://doi.org/10.25251/skin.10.supp.549.